Drugs / MVC-COV1901

Trials 15 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT05216601 May → Jul 2022 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 1 NCT04487210 Oct 2020 → Jun 2021 COVID-19 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT05132855 Nov 2021 → Apr 2023 COVID-19 Chang Gung Memorial Hospital Unknown No outcome recorded
Phase 27 trials
Phase 2 NCT05197153 Jan → Jun 2022 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 2 NCT05054621 Sep 2021 → Aug 2022 COVID-19 Chang Gung Memorial Hospital Completed No outcome recorded
Phase 2 NCT05038618 Aug → Oct 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 2 NCT04951388 Jul → Oct 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 2 NCT05048849 Jul → Nov 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 2 NCT04822025 May → Aug 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 2 NCT04695652 Dec 2020 → May 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 33 trials
Phase 3 NCT05198596 Jul → Nov 2022 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 3 NCT05426343 Jul → Oct 2022 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 3 NCT05011526 Oct → Dec 2021 Medigen Vaccine Biologics Corp. Completed No outcome recorded
Phase 42 trials
Phase 4 NCT05097053 Oct 2021 → Mar 2022 Taoyuan General Hospital Unknown No outcome recorded
Phase 4 NCT05079633 Sep → Oct 2021 National Taiwan University Hospital Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 17 sources stand behind the page.

FieldValueCited text
Known as MVC COV1901 “MVC-COV1901 is a protein vaccine based on the same SARS-CoV-2 strain used in mRNA vaccine mRNA-1273.” PMID 37321955 Jun 2023
15

“Medigen COVID-19 vaccine (MVC COV1901)” NCT05079633

NCT04487210

NCT05216601

NCT04951388

NCT04695652

NCT05097053

NCT05197153

NCT05198596

NCT05054621

NCT05048849

NCT04822025

NCT05426343

NCT05011526

NCT05132855

NCT05038618

Known as Medigen COVID-19 vaccine Medigen COVID-19 vaccine (MVC COV1901)” NCT05079633
Modality Vaccine “MVC-COV1901 is a protein subunit COVID-19 vaccinePMID 35579840 May 2022
Route Intramuscular “administered by intramuscular (IM) injection” NCT04487210